Evidence mapPaperPMID 36028839Full record

ReviewOrphanet journal of rare diseases2022

Estimation of hereditary fructose intolerance prevalence in the Chinese population.

Meiling Tang, Xiang Chen, Qi Ni, Yulan Lu, Bingbing Wu, Huijun Wang, Zhaoqing Yin, Wenhao Zhou, Xinran Dong

Open access · goldAbstract readReview
In one paragraph

Review in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Meiling Tang *Center for Molecular Medicine, Children's Hospital of Fudan University, Shanghai, China.
Xiang Chen *Department of Neonatology, Children's Hospital of Fudan University, Shanghai, 201102, China.
Qi NiCenter for Molecular Medicine, Children's Hospital of Fudan University, Shanghai, China.
Yulan LuCenter for Molecular Medicine, Children's Hospital of Fudan University, Shanghai, China.
Bingbing WuCenter for Molecular Medicine, Children's Hospital of Fudan University, Shanghai, China.
Huijun WangCenter for Molecular Medicine, Children's Hospital of Fudan University, Shanghai, China.
Zhaoqing YinDepartment of Pediatrics, Dehong Hospital of Kunming Medical University, Dehong, 678400, China.
Wenhao ZhouDepartment of Neonatology, Children's Hospital of Fudan University, Shanghai, 201102, China. zhouwenhao@fudan.edu.cn.
Xinran DongCenter for Molecular Medicine, Children's Hospital of Fudan University, Shanghai, China. xrdong@fudan.edu.cn.ORCID 0000-0001-9868-8795
Children's Hospital of Fudan University · CNKunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHereditary fructose intolerance (HFI) caused by aldolase B reduction or deficiency that results in fructose metabolism disorder. The disease prevalence in the Chinese population is unknown, which impedes the formulation of HFI screening and diagnosis strategies. MATERIALS AND

methodsBy searching a local cohort (Chinese Children's Rare Disease Genetic Testing Clinical Collaboration System, CCGT) and public databases (ClinVar and Human Gene Mutation Database) and reviewing HFI-related literature, we manually curated ALDOB pathogenic or likely pathogenic (P/LP) variants according to ACMG guidelines. Allele frequency (AF) information from the local database CCGT and the public databases HuaBiao and gnomAD for ALDOB P/LP variants was used to estimate and the HFI prevalence in the Chinese population and other populations by the Bayesian framework. We collected the genotype and clinical characteristics of HFI patients from the CCGT database and published literature to study genotype-phenotype relationships.

resultIn total, 81 variants of ALDOB were curated as P/LP. The estimated Chinese HFI prevalence was approximately 1/504,678, which was much lower than that for non-Finland European (1/23,147), Finnish in Finland (1/55,539), admixed American (1/132,801) and Ashkenazi Jewish (1/263,150) populations. By analyzing the genetic characteristics of ALDOB in the Chinese population, two variants (A338V, A338G) had significantly higher AFs in the Chinese population than in the non-Finland European population from gnomAD (all P values < 0.05). Five variants (A150P, A175D, N335K, R60*, R304Q) had significantly lower AFs (all P values < 0.1). The genotype-phenotype association analyses were based on 68 reported HFI patients from a literature review and the CCGT database. The results showed that patients carrying homozygous variant sites (especially A150P) were more likely to present nausea, and patients carrying two missense variant sites were more likely to present aversion to sweets and fruit (all P values < 0.05). Our research reveals that some gastrointestinal symptoms seem to be associated with certain genotypes.

conclusionThe prevalence of HFI in the Chinese population is extremely low, and there is no need to add HFI testing to the current newborn screening programs if medical costs are considered. A genetic testing strategy is suggested for early diagnosis of HFI.

Indexed as

Fructose IntoleranceBayes TheoremChildChinaFructose-Bisphosphate AldolaseHumansInfant, NewbornMutationPrevalenceFructose-Bisphosphate AldolaseAllele frequency comparisonCuration for pathogenic variantsHereditary fructose intoleranceNewborn screeningPrevalence estimation

Identifiers

PMID36028839
PMCPMC9419342
OpenAlexW4293175995

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.